Trial Profile

A Medicare reimbursed Phase III, multi-center, randomized, double-blinded, controlled study of CardiAMP Cell Therapy for Chronic Myocardial Ischemia

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 19 Nov 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

13 Nov 2024 According to a BioCardia media release, The last patient enrolled into the open-label roll-in cohort was treated in late August 2024 and primary endpoint data at six months to be expected in the first quarter of 2025.
14 May 2024 According to a BioCardia media release, data from the study were presented at the Technology and Heart Failure Therapeutics meeting on March 4, 2024.
14 May 2024 Results presented in the BioCardia Media Release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com